版本:
中国

BRIEF-Oncosec announces clinical collaboration with Merck

May 10 Oncosec Medical Inc

* Oncosec announces clinical collaboration with Merck to evaluate combination of immunopulse IL-12 and keytruda(pembrolizumab) for metastatic melanoma

* Additional details of collaboration were not disclosed

* Says under agreement, Oncosec will sponsor and fund study and Merck will provide keytruda Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐